Edition:
United Kingdom

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

1.91HKD
18 Apr 2019
Change (% chg)

HK$-0.02 (-1.04%)
Prev Close
HK$1.93
Open
HK$1.91
Day's High
HK$1.98
Day's Low
HK$1.90
Volume
14,927,114
Avg. Vol
13,588,888
52-wk High
HK$2.19
52-wk Low
HK$1.24

Latest Key Developments (Source: Significant Developments)

Sihuan Pharmaceutical Gets Registration Approval For Compound Amino Acid Injection
Monday, 18 Mar 2019 

March 18 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::COMPOUND AMINO ACID INJECTION (20AA) GETS APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA.  Full Article

Sihuan Pharmaceutical Holdings Says Compound Electrolyte Injection(II) Granted Drug Registration Approval
Monday, 10 Dec 2018 

Dec 11 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::COMPOUND ELECTROLYTE INJECTION (II) GRANTED DRUG REGISTRATION APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

Sihuan Pharmaceutical Group Drug Benapenem Commences Phase II Clinical Trial In China
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::CATEGORY 1 INNOVATIVE DRUG BENAPENEM COMMENCED PHASE II CLINICAL TRIAL IN CHINA.  Full Article

Hainan Sihuan Pharmaceutical to invest 200 mln yuan in Pharmadax Foshan unit
Monday, 4 Sep 2017 

Sept 4 (Reuters) - Pharmadax Inc <4191.TWO> ::* Says it and units signed agreement with Hainan Sihuan Pharmaceutical Co Ltd and Sihuan Pharmaceutical Holdings Group.* Hainan Sihuan Pharmaceutical Co Ltd plans to invest initial 200 million yuan in its Foshan-based pharma unit, to buy 19.99 percent stake and corporate bonds, for equity investment and strategic cooperation.  Full Article

Sihuan Pharmaceutical Holdings says HY revenue RMB1.44 bln
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>:HY profit attributable to owners of co up by 14.5 pct to about RMB842.5 million.HY revenue RMB1.44 billion, up 3.8 pct.Interim dividend RMB1.8 cents per share.  Full Article

Sihuan Pharmaceutical Holdings announces appointment of group vice president for research and development
Monday, 31 Jul 2017 

July 31 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::Appointment of Guo Feng as group vice president (research and development).Jia Zhongxin has retired recently as chief operating officer of group.  Full Article

Sihuan Pharmaceutical Holdings announces establishment joint venture
Monday, 12 Jun 2017 

June 12 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::Croma-Pharma recently received China food and drug administration-approval for Princess Volume dermal filler.Establishes joint venture on minimally-invasive aesthetic products.‍Sales of Princess Volume dermal filler is expected to start as early as July 2017​.  Full Article

Sihuan Pharmaceutical updates on deal with Buchang Pharma regarding distributorship of two products
Tuesday, 16 May 2017 

May 16 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::Company has recently entered into an agreement with Buchang Pharma with respect to distributorship of two products."Currently, Buchang Pharma has 100% equity interests in Tonghua Guhong, and intends to terminate distributorship arrangement with group".Following disposal of 50% interest in Jilin Sichang, group intends to retrieve its nationwide distributorship of Qunao from Buchang.As per distribution deal between co & Buchang, arrangement between Tonghua Guhong and Buchang on Guhong product shall be terminated.As per distribution deal between co & Buchang, arrangement between Jilin Sihuan and buchang on Qunao Product shall also be terminated.  Full Article